Adjuvant CapitalinField Notes by Adjuvant CapitalField Notes VWelcome back to Field Notes! Hope you enjoy this week’s mix!Nov 4, 2019Nov 4, 2019
Adjuvant CapitalinField Notes by Adjuvant CapitalField Notes VWelcome back! Sorry it’s been a while since our last Field Notes, but we’ve been busy with two new investments in InDevR and Themis…Sep 30, 2019Sep 30, 2019
Adjuvant CapitalinField Notes by Adjuvant CapitalField Notes IVWelcome back to fields notes! We’ve curated our favorite public health tidbits for your short week reading enjoyment!Sep 3, 2019Sep 3, 2019
Adjuvant CapitalinField Notes by Adjuvant CapitalField Notes IIIby Michael Chang and Charlie PettyAug 8, 2019Aug 8, 2019
Adjuvant Capital“Beating Herpes”: Adjuvant’s First Investment Targets a Daunting Viral InfectionAdjuvant participates in upsized $56 million Series A financing for X-Vax Technology, Inc.Jul 23, 2019Jul 23, 2019
Adjuvant CapitalinField Notes by Adjuvant CapitalField Notes Iby Michael Chang and Charlie PettyJul 2, 2019Jul 2, 2019